Millipore Acquires Rights to Disposable Manufacturing Technology for Biopharmaceutical Production
Bedford, Massachusetts, – Millipore Corporation announced it has acquired rights to new technology that enables the sterile filling of biopharmaceutical drugs in a closed, disposable system. The technology was licensed on an exclusive basis for biopharmaceutical applications from Filvek, LLC of Springfield, Vermont. Terms of the deal were not disclosed. Systems based on the new technology are expected to be in testing at customer sites within the next six months.
Susan Vogt, President of Millipore's Biopharmaceutical Division, noted: "This strategic licensing transaction extends our offering to biotech and pharmaceutical customers, and addresses the emerging disposable manufacturing market. It fits into our overall goal of providing complete purification solutions to our customers."
Mark Tanny, President of Filvek, said: "Millipore has the global infrastructure and reputation to accelerate the adoption of our disposable filling technology, and we're very pleased to be working with them. Millipore's disposable sterilizing filters fit right into the new system. "
Final filling is that part of drug production where bulk formulated drugs are dispensed into individual vials, ampoules or syringes. This final filling operation needs to be fast, sterile, robust, and accurate in terms of volumes dispensed. With a system based on the new technology, customers can fill solutions while minimizing disassembly, cleaning, sterilizing and re-assembly typical with current methods of final filling.
Stephen Tingley, Millipore's Biopharmaceutical Marketing Manager, noted: "There are labor and cost advantages to this new filling technology, as well as quality advantages in terms of reducing the possibility of cross-contamination. The new technology has an innovative approach to accurately dispensing drugs into each container, and can be easily retrofitted into existing filling lines."
Other news from the department science
These products might interest you

Cell culture filtration solutions by Cytiva
Cell culture filtration products
High-performance sterile filtration for media, protein purification, and cell culture

Sartopore®2 by Sartorius
Effective mycoplasma removal and sterilisation
Lowest filtration costs and maximum safety for your processes

Sartopore® Platinum by Sartorius
Efficient filtration with minimal protein adsorption
Reduces rinsing volume by 95 % and offers 1 m² filtration area per 10"

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.